We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novel ALS Therapy in Human Clinical Trials

News   Jul 17, 2018 | Original Story by Tamara Bhandari for WUSTL

 
Novel ALS Therapy in Human Clinical Trials

Robert Bucelli, MD, PhD, measures Gregory Easter's neuromuscular function. Easter, who has an inherited form of amytrophic lateral sclerosis, a fatal neuromuscular disease, is taking part in a clinical trial to evaluate an experimental drug. New research at Washington University School of Medicine in St. Louis shows the drug extends survival and reverses some neuromuscular damage in mice and rats and may help people whose disease is caused by mutations in the gene SOD1. Credit: Mike Worful, WUSTL.

 
 
 

RELATED ARTICLES

A Potential Role for Sperm in Repeat Miscarriages

News

In a new study, researchers analyze the potential role that sperm DNA damage may have in recurrent pregnancy loss.

READ MORE

Nanotechnology Approach for Treating Aggressive Breast Cancer

News

Triple negative breast cancer has no currently approved targeted therapies for treatment. Utilizing nanotechnology, a research group have developed a method that targets specific genes in triple negative breast cancer, killing cancerous cells.

READ MORE

Team Sport Participation Linked to Brain Changes in Children

News

Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE